Logo

synthetic biology

Hexagon Bio Closes $77.3M Series B Financing Round

The metagenome-focused drug discovery and computational biology company will look to advance oncology infectious disease research to the candidate nomination stage.

Agbio Gene Editing Firm Cibus to Merge With Plant Synbio Company Calyxt

The newly merged company will retain the Cibus name and trade on the Nasdaq Capital Market, where Calyxt is currently listed.

French DNA Data Storage Startup Biomemory Raises €5M in Seed Funding

The DNA synthesis and data storage company will use the funds to further optimize and reduce the cost of its technologies.

Colossal Biosciences Informatics Spinoff Form Bio Launches With $30M in Series A Financing
Premium

The firm plans to commercialize computational biology and machine learning technology developed to support Colossal's species conservation and "de-extincting" efforts.

Lesaffre Acquires Recombia Biosciences

The deal builds on a strategic partnership between the firms that started in 2020 to design and develop yeasts to produce fermented ingredients and biofuels.

Breaking News
The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.